Stockreport

Aravive Receives Additional $2.6 Million Disbursement from the Cancer Prevention and Research Institute of Texas

Aravive, Inc.  (ARAV) 
Last aravive, inc. earnings: 3/27 08:00 am Check Earnings Report
PDF HOUSTON, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company, today announced that the company has received an a [Read more]